ATC code H03

From WikiMD's WELLNESSPEDIA

ATC codes
H Systemic hormonal preparations, excluding sex hormones and insulins
H01 Pituitary and hypothalamic hormones and analogues
H02 Corticosteroids for systemic use
H03 Thyroid therapy
H04 Pancreatic hormones
H05 Calcium homeostasis

A B C D G H QI J L M N P R S V
(Hover over links to see titles)



ATC code H03 Thyroid therapy is a therapeutic subgroup of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.[1][2] Subgroup H03 is part of the anatomical group H Systemic hormonal preparations, excluding sex hormones and insulins.[3]

Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QH03.[4]

National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.


H03A Thyroid preparations[edit]

H03AA Thyroid hormones[edit]

H03AA01 Levothyroxine sodium
H03AA02 Liothyronine sodium
H03AA03 Combinations of levothyroxine and liothyronine
H03AA04 Tiratricol
H03AA05 Thyroid gland preparations

H03B Antithyroid preparations[edit]

H03BA Thiouracils[edit]

H03BA01 Methylthiouracil
H03BA02 Propylthiouracil
H03BA03 Benzylthiouracil

H03BB Sulphur-containing imidazole derivatives[edit]

H03BB01 Carbimazole
H03BB02 Thiamazole
H03BB52 Thiamazole, combinations

H03BC Perchlorates[edit]

H03BC01 Potassium perchlorate

H03BX Other antithyroid preparations[edit]

H03BX01 Diiodotyrosine
H03BX02 Dibromotyrosine

H03C Iodine therapy[edit]

H03CA Iodine therapy[edit]

References[edit]

  1. ↑ ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis(link). National Institutes of Health.
  2. ↑ ATC-Klassifikation mit definierten Tagesdosen DDD(link). German Institute for Medical Documentation and Information.
  3. ↑ ATC/DDD Index 2022
    code H03(link). WHO Collaborating Centre for Drug Statistics Methodology.
  4. ↑ ATCvet Index 2022
    code QH03(link). WHO Collaborating Centre for Drug Statistics Methodology.


Thyroid therapy (H03)
Thyroid hormones
Antithyroid preparations


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=ATC_code_H03&oldid=6498073"